Our Impact at a Glance
What we achieved in 2021-2022:
200+
Portfolio trials supported
6230+
Patients recruited to portfolio trials
130+
Percent increase in patients above the pre-3CTN baseline
Stay Connected
News
Events
3CTN’s Annual Stakeholder Meeting (ASM) & Workshops 2023
3CTN is excited to announce that our upcoming Annual Stakeholder Meeti…